---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-049561"
form_type: "8-K"
ticker: "HEPA"
cik: "0001583771"
company_name: "Hepion Pharmaceuticals, Inc."
filed_at: "2024-12-11T23:59:59+00:00"
generated_at: "2026-05-29T04:42:45.366349+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Hepion terminates merger with Pharma Two B; special meeting cancelled

## Summary
- Merger Agreement with Pharma Two B Ltd. terminated mutually on Dec 10, 2024.
- No termination fee payable by either party.
- Special stockholders meeting scheduled for Dec 12, 2024 cancelled; proposals withdrawn.
- Nasdaq would not exclude historical losses from burn-rate calculation, leading to termination.

## SEC filing metadata
- accession: 0001493152-24-049561
- form_type: 8-K
- ticker: HEPA
- cik: 0001583771
- company_name: Hepion Pharmaceuticals, Inc.
- filed_at: 2024-12-11T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583771/000149315224049561/0001493152-24-049561-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583771/000149315224049561/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-049561
- JSON: https://secwatch.observer/filing/0001493152-24-049561.json
- Plain text: https://secwatch.observer/filing/0001493152-24-049561.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.